The objective of this study is to compare safety and efficacy of COLAL PRED with prednisolone in patients diagnosed with moderate acute ulcerative colitis by the following: To determine the optimum dose ie the dose that demonstrates non-inferiority to conventional prednisolone in terms of efficacy with a significant reduction or absence of steroid-related adverse effects To investigate the clinical differences in response between 40 60 and 80 mg of COLAL PRED in terms of safety and efficacy
Data and Resources
- A Multicentre Randomised Double-Blind Double-Dummy Active Comparator Controlled Parallel Group Study of COLAL PRED in the Treatment of Moderate Acute Ulcerative Colitisjson
The objective of this study is to compare safety and efficacy of COLAL PRED...
|Release Date|| |
|Public Access Level|| |